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Abstract
Background: It is well known that neurons of the peripheral nervous system have the capacity to
regenerate a severed axon leading to functional recovery, whereas neurons of the central nervous
system do not regenerate successfully after injury. The underlying molecular programs initiated by
axotomized peripheral and central nervous system neurons are not yet fully understood.
Results: To gain insight into the molecular mechanisms underlying the process of regeneration in
the nervous system, differential display polymerase chain reaction has been used to identify
differentially expressed genes following axotomy of peripheral and central nerve fibers. For this
purpose, axotomy induced changes of regenerating facial nucleus neurons, and non-regenerating
red nucleus and Clarke's nucleus neurons have been analyzed in an intra-animal side-to-side
comparison. One hundred and thirty five gene fragments have been isolated, of which 69
correspond to known genes encoding for a number of different functional classes of proteins such
as transcription factors, signaling molecules, homeobox-genes, receptors and proteins involved in
metabolism. Sixty gene fragments correspond to genomic mouse sequences without known
function. In situ-hybridization has been used to confirm differential expression and to analyze the
cellular localization of these gene fragments. Twenty one genes (~15%) have been demonstrated
to be differentially expressed.
Conclusions: The detailed analysis of differentially expressed genes in different lesion paradigms
provides new insights into the molecular mechanisms underlying the process of regeneration and
may lead to the identification of genes which play key roles in functional repair of central nervous
tissues.
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Background
Lesioned axons of the peripheral nervous system (PNS)
have the capacity to undergo successful regeneration lead-
ing to complete functional recovery. In marked contrast,
lesioned axons of the central nervous system (CNS) do
not demonstrate any functionally significant regenera-
tion. An important aspect underlying the opposing out-
come of injured PNS and CNS neurons are the different
molecular programs initiated in the axotomized neuronal
cell bodies [1,2]. One important step for the eventual suc-
cess or failure of a neuron to regenerate a severed axon is
the expression of important regeneration-associated genes
[2,3]. To date, there is currently relatively little informa-
tion available concerning the molecular and genetic pro-
grams which control such behavior.
In recent years, gene screening methods such as the DD-
PCR technique have greatly facilitated the identification
of differentially expressed genes. Pardee and co-workers
were the first to demonstrate that combinations of arbi-
trary primers with anchored cDNA primers can be success-
fully applied to generate gene fragments from the total
mRNA of one cell type [4,5]. In the following years vari-
ous modifications have been developed and several re-
search groups have successfully used this technique to
investigate complex biological problems, e.g. during the
development of tumors, neuropathies, endocrinology or
ischemia [4–6]. In the neuroscience field, several reports
have demonstrated that important regeneration-associat-
ed genes can be identified by the DD-PCR technique [7–
11]. However, we are still far from understanding the pre-
cise mechanisms involved in the process of regeneration
because only a restricted number of molecules have been
examined in detail and the existence of other important as
yet unidentified molecules is very likely.
In our present investigation, we have applied DD-PCR to
analyze the gene expression pattern of regenerating and
non-regenerating populations of neurons. For this pur-
pose we have used the model of spinal cord hemisection
as a non-regenerating lesion paradigm and transection of
the facial nerve as a regenerating lesion paradigm. The ret-
rograde reactions of axotomized regenerating neurons of
the facial nucleus and non-regenerating neurons of the
red and Clarke's nucleus can be investigated following
these lesions. Both lesion models are well established and
have been the basis for a number of investigations to ana-
lyze the cellular and molecular mechanisms underlying
the process of regeneration. After transection of the facial
nerve, a sequence of events takes place which usually leads
to axonal elongation, re-innervation and functional re-
covery within a few weeks (for review see [12]. This ap-
proach has allowed numerous investigators to study
retrograde changes of axotomized neurons of the facial
nucleus which could be correlated with successful regen-
eration [13–17]. One important advantage of this model
is that the blood brain barrier is not broken down after
nerve transection. This avoids additional involvement by
invading inflammatory cells [18]. By this lesion paradigm
a number of classes of molecules have been investigated,
including cytokines, transcription factors, adhesion mole-
cules, signaling molecules etc. [13–17,19]. The differen-
tial expression of such molecules has been observed quite
early (several hours to a few days) after a lesion and usu-
ally lasts for approximately two weeks [13,14,16,17,20].
The hemisection model leads to axotomy of contralateral
rubrospinal neurons rostral to the lesion and also ispilat-
eral Clarke's nucleus neurons caudal to the lesion. Both
types of neurons are located in anatomically well defined
nuclei and have been the used for a number of studies to
analyze retrograde reactions of CNS neurons [2,21–25].
Both types of neurons do not spontaneously regenerate.
Rubrospinal neurons atrophy after axotomy but a sub-
population of Clarke's nucleus neurons degenerate after
axotomy [2,21,26–28]. Nonetheless, both types of CNS
neurons demonstrate regenerative "capacities". They can
be "rescued" by neurotrophic factors and their axons can
regenerate into growth permissive environments trans-
planted into the lesion site [22,27–30]. Both types of CNS
neurons also show similar molecular responses with the
up-regulation of regeneration-associated genes, such as
GAP-43 and c-jun [1,24,31]. These responses support the
notion of an intrinsic regenerative capacity (for review see
[32]. Since most of these molecular events take place at
early after injury and peak at approximately one week, we
decided to chose the 7 day post lesion time point for the
differential screening.
We have isolated 180 differentially expressed bands which
corresponded to 135 different gene fragments of which 69
showed high homology to known sequences and 60
showed homologies to different regions of different
mouse chromosomes. Genes with known sequences
could be classified into major groups belonging to tran-
scription factors, signal transduction pathways, home-
obox-genes, receptors, molecules involved in protein and
lipid metabolism, cytoskeletal and miscellaneous mole-
cules. In situ-hybridization has been performed to prove
the differential expression in vivo. These results contribute
to elucidate the molecular mechanisms underlying the
process of regeneration.
Results
Identification of regeneration-associated genes
We have performed radioactive DD-PCR using a set of ar-
bitrary primers labeled with 35S-dATP (Table 1). This tech-
nical approach is more sensitive compared with non-
radioactive DD-PCR (e.g. loading PCR products on agar-
ose gels visualized by ethidium bromide). Even gene frag-
ments with low expression could be identified (Fig. 1).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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For reducing the number of false-positives, duplicated
DD-PCR runs were performed for each sample and PCR
products were loaded onto the same gel. Only bands
(fragments) which appeared to be differentially expressed
in both of the duplicated lanes were used for further anal-
ysis (Fig. 1). We have thus isolated 180 fragments, 135 of
which could be successfully reamplified. After sequencing
and gene bank (NCBI) analysis, we have obtained 135 dif-
ferentially expressed genes. Sixty nine of the gene frag-
ments revealed a high homology to known genes, which
encoded for proteins with a number of different functions
reflecting the complexity of the process of regeneration.
The known genes could be classified into several major
groups (Table 2), of which a high number (39) were tran-
scription factors, homeobox-genes and genes involved in
signaling pathways or metabolism. Six gene fragments did
not show homologies to sequences in the gene bank. The
additional comparison with the mouse genome, which
has been recently published, revealed 60 gene fragments
showing homologies to different regions of several mouse
chromosomes with unknown function (Table 4).
Verification of the differential expression by ISH
For confirming differential expression, we used non-radi-
oactive ISH which allows the detection of the anatomical
and cellular distribution of gene expression, thereby facil-
itating the interpretation of the functional role of these
genes. By ISH analysis, differential expression of 21 genes
could be confirmed (Table 3). This number represents
~15% of the total DD-PCR fragments and is in keeping
with similar studies in other laboratories. However, it can
not be excluded that the lack of detection by ISH for a cer-
tain number of genes is due to technical reasons. Sixteen
genes with confirmed differential expression demonstrat-
ed either up- or down-regulation in neurons, 5 in glial
cells (Table 3). The differential expression of transferrin
receptor, P4-kinase, STAT-5 and connexin-43 confirm al-
ready published studies from other research groups
[16,33–35]. To the best of our knowledge, this is the first
demonstration of differential expression of the other
genes such as the Na+/K+-ATPase which is down-regulated
after facial nerve lesion (Fig. 2A,2B).
Table 1: Set of different arbitrary primers used for DD-PCR
HAP25 AAG CTT TCC TGG A
HAP26 AAG CTT GCC ATG G
HAP27 AAG CTT CTG CTG G
HAP28 AAG CTT ACT ATG C
HAP29 AAG CTT AGC AGC A
HAP30 AAG CTT CGT ACG T
HAP31 AAG CTT GGT GAA C
HAP32 AAG CTT CCT GCA A
Figure 1
Detection of differentially expressed genes after facial nerve 
transection Radioactive labeled DD-PCR fragments after 
electrophoretic separation using a polyacrylamide gel and 
exposition to an x-ray film. Gel image illustrates that frag-
ments with high and low expression can be identified. Lanes 
1 and 2 represent the operated side. Lanes 3 and 4 represent 
the un-operated side (facial nucleus). By comparing operated 
and control side, fragments which are considered to be dif-
ferentially displayed appear in both lanes for either operated 
or un-operated sides (arrows). Fragments indicating either 
up- or down-regulation have been chosen for further 
analysis.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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Table 2: DD-PCR fragments which indicated differential expression between axotomized versus non-axotomized neurons. (Accession 
Nr.).
Clarke's and Red nucleus Facial nucleus
Transcription factors Histone acetylase (MRG15) C-maf (AF 055376)
MORF (BC 003894) OCT-2 (X67302)
C-FOS (X06791) ETS-like protein (D61707)
Deaconesstranscriptionfactor (409229.1)
NF1(L4) (X84210)
NF1-X1 (AB012235)
TTF-1 (AJ 296303)
JUN B (X 54686.1)
C-FOS (X06791)
Homeobox genes Hox-9 (AB027042) HOX-1 (S76296.1)
HOX-3 (S76303.1)
HOX-4 (X62699.1)
R1a homeobox gene (M37565)
Signal transduction Phospholipase A2 (U 38376) Phosphatidylinositol-4-kinase (S56508)
STAT 5b (AF 234171.2)
GDP-releasing protein (L10336)
Phosphatase-1 binding protein (U89924)
Gro (D11444)
Receptors Androgen receptor (M23264.1) Transferrin receptor (M58040)
B-cell receptor ass. Protein BAP29 (X78684)
T-cell receptor (AE008685)
Metabolism Human esterase D (AF112219) Elongation factor-1 (M95792)
Elongation factor-2 (AF0005761) Elongation factor-2 (AF0005761)
Alkyl-dihydroxyacetone phosphate synthase (Y08826) Ribosomal protein S3 (X515361.1)
Ribosomal protein S6 (M29358)
Phosphoribolsyl transferase (X16554.1) Ribosomal protein L7 (X57961.1)
Phosphoribosylpyrophosphate synthetase (M31084) NADH-ubichinone-oxidoreductase (D86215)
Pyruvat-Kinase (X05684.1)
N-acetyltransferase (L10245.1) NADH dehydrogenase subunit1. (X07479)
Stearoyl-CoA-desaturase-1 (J02585)
TRNA synthase (NM003191.1)
TRNA-trp (N27315.1)
NADH dehydrogenase subunit1. (X07479)
Phosphatase 1 binding protein (MMU89924)
Cytoskeletal proteins Hax-1 (NM011826.1) Myosin light chain (S77858.1)
Vimentin (Y077301) Vimentin (Y077301)
Adhesion molecules Putative neuronal cell adhesion molecule (AF026466)
Integrin α6 subunit (X69902)
Miscellaneous Chaperonin (AB022158.1) Conexin-43 (NM012567)
Oxysterol binding protein (AB017026) α-B-crystallin (D29960)
ATP-sensitive inwardly rectifying K+-channel (D86039) Ferritin light chain (J02741)
Chaperonin (HSP60) (U68562.1)
N-ethylmaleimide sens. factor (AF189019) GAP-Junction protein (BC011324.1)
Cecum cDNA (AK018679.1) 3beta-Hydroxysteroid Dehydrogenase isomerase 
(S63167.1)
Synuclein β (NM033610.2)
Tubby-like protein (AJ296303) ubiquitin specific protease (BC027052.1)
TNF converting enzyme (AF056357.1)
Retrotransposon (AF000199.1)
Collagen V (NM134452.1)
Na+/K+-ATP'ase (β-1 Subunit) (M 14137.1)
Rat clone rp32-47 (AC092531.16)
Acatn gene for acetyl.CoA (AB037364.1)
Unknown 4 sequences 2BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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Figure 2
Differentially expressed genes within axotomized facial nucleus neurons. A,B: ISH of ATPase after unilateral transection of the 
facial nucleus. By comparing mRNA expression in the control (A) and operated (B) side, mRNA down-regulation could be 
detected within axotomized neurons. C,D: ISH of clone U27 after unilateral transection of the facial nucleus. Dramatic mRNA 
up-regulation could be detected within axotomized facial nucleus neurons (D) compared with the control side (C). D,E: ISH of 
clone U41 after transection of the facial nucleus. No differential mRNA expression could be detected in the facial nucleus neu-
rons following injury. (A) Control and (B) operated side. Bar, 100 µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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Table 3: Genes with confirmed up-(↑) or down-(↓)regulation
Regulated in the facial nucleus Regulated in the Red or Clarke's nucleus
c-maf (neuronal↑) B cell receptor (neuronal↓)
Connexin-43 (glial↑) Hox-9 (neuronal↓)
Ef-2 (neuronal↑)N a +/K+-ATPase (neuronal↓)
Ferritin light chain (neuronal↑) Vimentin (glial↑)
oct2 (neuronal↑)
P4 kinase (neuronal ↓) 2 novel sequences (neuronal↑)
Ribosomal protein S3 (glial↑)
Ribosomal protein S6 (glial↑)
Ribosomal protein L7 (glial↑)
SCD-1 (neuronal↑)
STAT-5 (neuronal↑)
Transferrinreceptor(neuronal↑)
3 novel sequences (neuronal↑)
Table 4: List of DD-PCR fragments matching with the mouse genome (sequences can be obtained on request from the authors)
clone Chromosome 
(region)
Homology (%) Accessionnr. 
(NCBI)
Clone Chromosome 
(region)
Homology (%) Accession Nr. (NCBI)
U1 12 (C3) 80 U31 4 (D1) 76
U2 X 86 AL773583.9 U32 X (A3.3) 70
U3 11 (B1.3) 71 U33 X (D) 65
U4 16 (C3.3) 84 U34 2 86 AL845542.9
U5 11 86 AL772225.5 U35 19 (C1) 80
U6 9 (F1) 83 U36 1 (A5) 76
U7 X 86 AL691418.9 U37 1 (C1) 81
U8 10 (A2) 75 U38 10 (A3) 78
U9 18 (E3) 79 U39 8 (E2) 80
U10 16 (A3) 78 U40 10 (B4) 78
U11 11 89 AL663083.5 U41 15 (D2) 75
U12 3 (H1) 73 U42 9 (F4) 68
U13 18 (B3) 85 U43 1 (C1) 74
U14 9 (A5.2) 79 U44 16 (C1.2) 73
U15 5 85 AC122862.4 U45 4 87 AL645625.15
U16 12 (F2) 78 U46 10 (A3/A4) 82
U17 X (F5) 82 U47 4 (B3) 82
U18 16 (A1) 72 U48 2 (H3) 77
U19 14 (C2) 82 U49 15 (A2) 83
U20 3 (A2) 75 U50 13 (A3.3) 78
U21 19 (B) 82 U51 11 (B1.1) 85
U22 15 (D2) 75 U52 X 84 AL772348.2
U23 18 (B3) 85 U53 98 5
U24 13 (A5) 87 U54 12 (B1) 85
U25 7 90 AC126435.3 U55 2 96 AL591430.8
U26 4 87 AL645625.15 U56 18 86 AL669931.9
U27 14 (C2) 82 U57 16 83 AC090121.37
U28 3 (A2) 74 U58 8 (A2) 98
U29 1 (G2) 82 U59 7 (F4) 83
U30 2 (C1) 76 U60 13 (B2) 89BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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To facilitate the selection of genes for future functional
analysis, we have performed comparative studies in a
number of different lesion paradigms. ISH analysis of the
gene expression in regenerating and non-regenerating
models allows the identification of those genes which are
either exclusively regulated in a regenerating or a non-re-
generating system or show a different regulation pattern
between the two systems. To date, we have compared the
expression pattern of a few selected genes in different
models. In particular, all gene fragments matching with
the mouse genome (Table 4) have been analyzed by ISH
in our different lesion paradigms. Four of those gene frag-
ments were exclusively regulated in one lesion model. All
3 gene fragments which have been identified using the fa-
cial nucleus model such as clone U27 showed dramatic
up-regulation in the axotomized facial nucleus neurons
(Fig. 2B,2C), but not in axotomized red or Clarke's nucle-
us neurons. One gene fragment which has been obtained
after spinal cord lesion is up-regulated in axotomized red
nucleus neurons, but not in facial or Clarke's nucleus neu-
rons after injury (data not shown). One gene fragment
(Clone U41), which has been obtained from the Clarke's
nucleus after spinal cord hemisection, showed a different
regulation pattern between regenerating and non-regener-
ating neurons. No differential expression could be ob-
served within axotomized facial nucleus neurons (Fig.
2E,2F). In contrast, a dramatic mRNA up-regulation of
clone U41 could be detected within axotomized neurons
either of the Clarke's nucleus (Fig. 3A,3B) or red nucleus
(Fig. 2D,2E,2F). These results demonstrate that clone U41
is exclusively regulated in non-regenerating CNS neurons.
Discussion
Injured CNS axons do not demonstrate any significant re-
generation, whereas axotomy of PNS axons can lead to
functional recovery (for review [36]). The underlying mo-
lecular mechanisms are only partially understood.
Peripheral nerve injury induces changes in the molecular
program of the injured neurons which include up-regula-
tion of the immediate early genes (e.g. c-Jun) followed by
regeneration-associated genes such as GAP-43 (for review
[12]). Some similar reactions have also been observed in
axotomized CNS neurons, but this response is rather
"short-lived" and does not lead to any functional regener-
ation [2,24,31].
In our present study, we have investigated the gene expres-
sion pattern of regenerating facial nucleus neurons and
non-regenerating red and Clarke's nucleus neurons after
axotomy using the DD-PCR method. This allows the iden-
tification of similarities and differences in the molecular
reactions of the lesioned PNS and CNS neurons. The le-
sion paradigms chosen for the present investigation are
widely acknowledged and popular models of PNS and
CNS injuries. Since a large number of molecules are
known to be differentially expressed at approximately 7
days after injury [1,13,16,17,24,31,37], we have chosen
this time point for our DD-PCR analysis. Subsequent ISH
analysis has been applied to prove the differential expres-
sion of these genes in vivo, revealing the anatomical and
cellular localization. Since the identification of the cellu-
lar localization of the gene of interest facilitates the inter-
pretation of its functional role, ISH represents the ideal
tool for the verification of differential expression.
Sixty nine gene fragments showed high homologies to
known gene sequences. Most of the identified genes could
be divided into different groups belonging to transcrip-
tion factors, homeobox-genes, genes involved in signaling
pathways or metabolism, receptors and cytoskeletal mol-
ecules (Table 2). The group of miscellenous genes encod-
ed for a variety of proteins with specific functions. The
high number of different genes related to different groups
associated with the process of regeneration reflects the
complexity of this issue. In a similar, very extensive study,
using micro array analysis, Costigan and co-workers iden-
tified a vast number of differentially expressed genes with-
in axotomized sensory neurons after sciatic nerve
transection [7]. Similar to our results, these genes encode
for different classes of proteins.
However, we were surprised not having detected genes en-
coding for neuropeptides or transmitters. It is likely that
this is simply due to chance. The screening was halted
when we had obtained 180 differentially expressed mR-
NAs. We believe that, had we performed an even more ex-
tensive screen, we would indeed have identified mRNAs
corresponding to neuropeptides or transmitters.
We have identified several transcriptions factors in this in-
vestigation. This is not a major surprise, because the pro-
tein synthesis is largely regulated by gene transcription.
Transcription factors are proteins which may recognize
specific binding sites of a number of genes, regulating
their activation [38]. A number of studies have already
demonstrated that transcription factors such as c-jun or
STAT-3 play a significant role for the processes of regener-
ation and degeneration [3,16,39–41]. In our investiga-
tions, c-maf and Oct-2 are induced in axotomized facial
nucleus neurons. The transcription factor Oct-2 is belong-
ing to the POU family and is induced in sensory neurons
after sciatic nerve transection [42]. It is known that the ex-
pression of Oct-2 is influenced by the nerve growth factor
(NGF) and might therefore be affected by the removal of
target derived NGF following axotomy. This up-regulation
of Oct-2 has been suggested to induce the phenotypic
changes involved in the neuronal response to injury [42].
C-maf is known to be expressed during embryogenesis
and is involved in cell differentiation. No data are availa-
ble for an involvement in the process of regeneration.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
Page 8 of 13
(page number not for citation purposes)
Figure 3
Differentially expressed genes within red and Clarke's nuclei. Non-radioactive ISH illustrates the differential expression of 
clone U41 seven days after spinal cord hemisection. A: Dramatic up-regulation of mRNA of clone U41 within axotomized 
Clarke's nucleus neurons (small arrows) ipsilateral and caudal to the lesion. Clarke's nucleus neurons of the control, non-oper-
ated side (large arrow) show only very faint expression. Bar, 100 µm B: High magnification of axotomized Clarke's nucleus neu-
rons (arrows) demonstrates increased mRNA expression of clone U41. Bar, 20 µm C: Negative control for ISH using a sense 
probe. Bar, 100 µm D: Low magnification of the midbrain at the level of red nucleus. Up-regulation of clone U41 has been 
detected within axotomized red nucleus neurons, contalateral to the lesion (OP). Red nucleus neurons of the control side 
(CON) show only faint expression. Bar, 400 µm E: High magnification of red nucleus contralateral to the lesion reveals 
increased mRNA expression of clone U41 within axotomized neurons. Bar, 100 µm F: Red nucleus neurons of the control side 
showing weak mRNA expression. Bar, 100 µmBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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However, it is known that post-traumatic regenerative
events in the nervous system often recapitulate some of
the molecular systems that were employed during devel-
opment [43]. In this context, the differential expression of
homeobox-genes such as Hox-9 might recapitulate their
role during embryonic ontogenesis. Homeobox-genes are
important for the establishment of the specific identity of
a cell and its topographic organization [44,45]. Previous
investigations have revealed that the homeobox-gene,
Islet-1, is down-regulated in axotomized facial nucleus
neurons. Islet-1 is a key marker for motoneurons during
development and this down-regulation might reflect a
loss of neuronal identity or some form of de-differentia-
tion. This might be an important prerequisite for neuron-
al regeneration [37].
We have also identified genes involved in signal transduc-
tion pathways and metabolism. These classes of mole-
cules have also been identified by others using similar
experimental approaches [46,47]. Specific signal trans-
duction pathways are involved in almost every cellular
process [48]. They are rapidly activated and may play key
roles in the regulation of differential gene expression [49].
It is very likely that the identification of genes involved in
metabolism rather reflects the functional stage of the cells
than being key elements for the process of regeneration.
However, ISH demonstrated the differential expression of
several genes influencing protein translation, which might
reflect an interesting aspect of the process of regeneration
which has, to date, been poorly appreciated. In the axot-
omized facial nucleus, genes encoding for proteins of the
small (S3 and S6) and large (L7) ribosomal subunits were
up-regulated in glial cells. In axotomized neurons, a gene
fragment homologue to the mouse elongation factor-2
(eEF2) showed enhanced neuronal expression. The differ-
ence to the published sequence for rat eEF2 suggests an
unknown isoform. It could be hypothesized that the bal-
ance of these molecules might control the rate of protein
translation leading to selective production of specific
mRNA species.
One interesting molecule identified in the present investi-
gation might be the enzyme stearoyl-CoA desaturase
(SCD-1), which is dramatically up-regulated in axot-
omized facial nucleus neurons. One of the preferred sub-
strates, stearoyl-CoA, is desaturated into oleoyl-CoA,
which is further converted into its corresponding fatty ac-
id: oleate. Beside its function as an energy store in the
form of triacylglycerides, oleate is part of biological cell
membranes and is believed to be involved in protein ki-
nase C (PKC) dependent second messenger cascades,
thereby influencing, for example, the activation of regen-
eration-associated genes such as GAP-43 [50,51]. By using
comparative studies, we have demonstrated that SCD-1 is
not induced in non-regenerating rubrospinal or Clarke's
nucleus neurons suggesting a significant role for success-
ful neuronal regeneration (Breuer et al., submitted for
publication).
Furthermore, we have identified receptors and cytoskele-
tal molecules. The role of the transferrin and B-cell recep-
tors being differentially expressed in the axotomized facial
nucleus [33] or red nucleus respectively, remains unclear.
However, it could be demonstrated that the lack of func-
tional B and T lymphocytes led to a significant loss of ax-
otomized facial nucleus neurons [52,53]. These results
highlight that the immune system is heavily involved in
regulating neuronal survival after peripheral nerve injury
[54–56]. Cytoskeletal elements such as GFAP or vimentin
are well known to be up-regulated in glial cells when they
respond to different types of injury which reflects a typical
feature of accompanying glial reactions [57,58].
Among the group of miscellenous genes, differential ex-
pression of connexin-43, ferritin light chain and the β-1
subunit of the Na/K-ATPase were identified. Connexin-43
(Cx-43) has already been reported to be up-regulated in
glial cells surrounding axotomized facial nucleus neurons.
The role of the induction of ferritin light chain within ax-
otomized facial nucleus neurons remains to be elucidat-
ed. Very little is known about the involvement of iron
metabolism in the axonal regeneration. However, ferritin
is known to be the major iron storage protein and is a key
component in protecting the brain from iron induced ox-
idative damage [59]. The β1-subunit of Na/K-ATPase was
down-regulated in axotomized Clarke's nucleus neurons.
It has been already demonstrated that the alpha 3 subunit
mRNA is reduced in ventral horn neurons after spinal
cord transection. This reduction could be reversed by dex-
amethasone, indicating that the expression of Na/K-AT-
Pase may constitute an important mechanism by which
glucocorticoids help to re-establish neuronal function
after injury [60]. Furthermore, the alpha 2 and beta isofor-
ms of Na/K-ATPase are down-regulated after sciatic nerve
injury. This reduction took place in the distal segments
owing to Wallerian degeneration and returned to baseline
during nerve regeneration [61]. These data suggest a func-
tional role for the process of regeneration which has to be
proven by further studies.
Furthermore, 66 gene fragments did not show homolo-
gies to known sequences of the rat genome. Since the rat
and mouse genomes are known to be very similar, we
compared our "unknown" sequences obtained from rat
RNAs with the mouse genome, which was recently pub-
lished. As anticipated, we found many homologies to the
mouse genome. Sixty gene fragments showed homologies
to different regions on different mouse chromosomes (Ta-
ble 4). It is likely that these gene fragments are related to
the corresponding sequences on the rat genome, whichBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
Page 10 of 13
(page number not for citation purposes)
have not yet been identified. ISH demonstrated that 3 of
those genes were up-regulated in axotomized facial nucle-
us neurons. One gene was up-regulated in axotomized ru-
brospinal neurons and one gene was down-regulated in
axotomized Clarke's nucleus neurons.
Although the DD-PCR technique leads to the rapid iden-
tification of a number of differentially expressed genes, a
major problem lies in the selection of genes for further
studies. It has to be considered, that the elucidation of the
functional role of defined genes and their products is very
time consuming. In the past, several other techniques
such as subtractive suppression hybridization (SSH) or se-
rial analysis of gene expression (SAGE) have been devel-
oped to analyze differentially expressed genes. Recently,
even more advanced methods such as arrays and DNA
chip analysis have been introduced. However, all of these
techniques lead to the identification of a high number of
differentially expressed genes and this leads to the limita-
tions of what can be quantitatively and qualitatively ana-
lyzed by one research group. All new techniques do not
solve the problem of identifying which genes have to be
selected for further detailed analysis. Therefore, other
strategies are necessary to facilitate this selection. In our
studies we have decided to performed comparative studies
using different lesion paradigms. Genes which have been
identified by DD-PCR and have been proven to be differ-
entially expressed using ISH will be analyzed in our differ-
ent lesion paradigms. The comparison of data from
regenerating and non-regenerating models facilitates the
identification of those genes that are regulated in a „mod-
el-specific" manner and those that may be of general
importance for the process of regeneration. By these com-
parative analyses, we will select genes for further investi-
gation which are exclusively regulated in a regenerating or
non-regenerating lesion paradigm or show different regu-
lation pattern.
So far, we have compared the gene expression pattern of a
few selected genes identified by the DD-PCR in all our le-
sion models. By this means, we have demonstrated that 4
gene fragments showing homologies to the mouse ge-
nome are exclusively regulated in one lesion paradigm. In
contrast, mRNA up-regulation of one of those gene frag-
ments could also be detected in non-regenerating neurons
of the red and Clarke's nucleus, but not in regenerating fa-
cial nucleus neurons. Such molecular differences between
regenerating and non-regenerating neurons could be
observed for the stearoyl-CoA-desaturase. SCD-1 is in-
duced in regenerating facial nucleus neurons, but not in
non-regenerating neurons of red and Clarke's nucleus.
Thus, these genes fulfill the criteria of being exclusively
regulated in only one lesion paradigm, indicating the im-
portance of the functional role in the process of regenera-
tion. These examples will provide the impetus for detailed
functional analysis (e.g. antisense or gene transfer studies)
of these genes.
Conclusions
By means of the differential display technique, we have
identified 135 genes belonging to different classes of
molecules. For 15% of the identified genes, the differen-
tial expression could be verified by ISH. In particular, the
strategy of employing differential display PCR in the com-
parison of regenerating and non-regenerating populations
of neurons significantly facilitates the identification of
genes which may a key role in the process of axonal re-
growth. Our results provide insights into the molecular
mechanisms underlying the final outcome of attempted
nerve fiber regeneration following axotomy. In particular,
genes that are exclusively regulated in a regenerating or
non-regenerating paradigm, might indicate an important
role in attempted tissue repair. Further studies will deter-
mine the functional significance of these molecules in the
process of regeneration.
Methods
Lesion models
All surgical procedures were performed on female
sprague-dawley rats (250 g) and were approved by the
government of Nordrhein-Westfalen (50.203.2 AC 23,21/
00) and the government of Oberbayern (211-2531-37/
97).
Peripheral nerve transection
The right facial nerve was transected outside the foramen
stylomastoideum under deep chloral hydrate anesthesia
(350 mg/kg, i.p.). Seven days after surgery, 10 rats for each
lesion model were given terminal anesthesia (chloral hy-
drate, 640 mg/kg i.p.). For DD-PCR, the animals were per-
fused via the left ventricle with sterile saline (0.9%). The
brains were immediately removed and frozen in liquid ni-
trogen. For in situ-hybridization, 4 animals for each lesion
model were perfused with 4% paraformaldehyde and
brains were removed for subsequent paraffin embedding.
Spinal cord hemisection
Under deep chloral hydrate anesthesia (350 mg/kg, i.p.) a
Th9 or C2 laminectomy was followed by lateral hemisec-
tion of the spinal cord. Seven days after injury, rats were
given terminal anesthesia (chloral hydrate, 640 mg/kg
i.p.). For DD-PCR, the animals were perfused via the left
ventricle with sterile saline (0.9%), the spinal cords (in-
cluding the lesion site) were rapidly dissected and frozen
in liquid nitrogen. For each animal, serial transverse (20
µm thick) sections of the lesion site were stained with
thionin to assess the accuracy and extent of the lesion. Spi-
nal cords with confirmed lateral hemisection were proc-
essed, together with the corresponding brains, for further
analysis. For in situ-hybridization, animals were perfusedBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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with 4% paraformaldehyde, the spinal cords and the
brains were removed and subsequently processed for par-
affin embedding.
RNA isolation and cDNA synthesis
For RNA isolation, the area of axotomized and non axot-
omized nuclei (facial, Clarke's and red nucleus neurons)
were punched out separately. The tissue was mechanically
homogenized and the RNA was isolated using TriStar
(Peqlab) according to the manufacturers protocol. To
eliminate genomic DNA an incubation (30 min) with 20
U DNAse (Boehringer Mannheim, Germany) was per-
formed. For cDNA synthesis, 1 µg of the RNA, 2 µl RNAsin
(40 U/µl) and 175 pmol T11A primer (AAG CTT TTT TTT
TTT A) were incubated 10 min. at 70°C and subsequently
cooled on ice. Six µl of reaction buffer (5X), 7 µl dNTP's
(each 2 mM), 1 µl MgCl2 (50 mM), 2 µl RNA'sin (40 U/
µl, Boehringer Mannheim, Germany), 1 µl AMV (30 U/µl,
Peqlab, Germany) and DEPC-water were added to a total
volume of 30 µl. After an incubation of 60 min. at 42°C,
the reaction was stopped by a 5 min. incubation at 94°C.
As an internal control for the content and quality of the
cDNAs, the housekeeping gene cyclophillin was used, am-
plified by PCR (5' primer: CAA CTC TAA TTT CTT TGA
CTT GCG GG; 3'primer: AGA GAT TAC AGG GTA TTG
CGA G). If necessary, the amount of cDNA used for the
PCR was adjusted.
Differential display PCR
All animals used for DD-PCR were sacrificed 7 days p.o.
To avoid false positive results due to an unequally
performed PCR, all runs were carried out in parallel (2 ×
operated and 2 × non operated). Radioactive DD-PCR ex-
periments were performed using one arbitrary primer
(Tab. 1) and one T11-A primer (AAG CTT TTT TTT TTT A).
The PCR reaction was performed in a volume of 12,5 µl
and contained 1 × PCR buffer, 20 pmol/µl dNTP's (each),
0,5 µl 35S-dATP (Amersham, SJ-1304), 0,2 pmol/µl prim-
er (each), 3 mM MgCl2, 5 U Taq-Polymerase (Sigma) and
5 µl cDNA. PCR was started by an initial incubation at
94°C for 2 min, followed by 48 cycles of 10 s at 91°C, 20
s at 40°C and 40 s. at 72°C. The resulting PCR products
were separated using 6% polyacrylamide gels and exposed
to an x-ray film (Kodak). Differentially expressed bands
were cut out, extracted by an incubation in 100 µl boiling
H2O for 15 min and precipitated with ethanol. The pellet
was resolved in 10 µl H2O. To reamplify the isolated
bands, a second PCR was performed in a volume of 12,5
µl, containing 1 µl isolated DNA, 1 × PCR buffer, 200 pM/
µl dNTP's (each), 1 pmol/µl primer (used in the first
PCR), 1,5 mM MgCl2, 2,5 U Taq-Polymerase (Sigma). Af-
ter successful amplification and purification (Qiaquick;
Qiagen; Hilden Germany), the isolated DNA was cloned
into a transcription vector (p-zero1-1, Invitrogen) and
sequenced with an automatic sequencer. By comparing
the sequences with known sequences in the gene bank of
the NCBI (National Center for Biotechnology Informa-
tion) we separated all clones which contain only bacterial-
or vector-DNA. Gene fragments which did not show ho-
mologies to known sequences were addionally compared
with the mouse genome http://www.ensembl.org.
In situ hybridization
Antisense and Sense RNA probes were generated for ISH,
which allowed the anatomical and cellular distribution of
genes identified by DD-PCR to be detected. This facilitates
the interpretation of a functional role for these genes.
For PCR amplification 0.5–1 ng of the cloned DD-PCR
fragments were used. Primers specific for either the T7 or
Sp6 RNA-polymerase recognition sequence were chosen.
A PCR with a volume of 12.5 µl containing 0.2 ng plasmid
was performed for 28 cycles with denaturation at 94°C for
10 s, annealing at 52°C for 10 sec and elongation at 74°C
for 20 s. The PCR product was purified from primers and
salt using QiaQuick (Qiagen, Hilden, Germany). Tran-
scription, using either T7 or Sp6 RNA-polymerase, was per-
formed according to the manufacturers protocol
(Boehringer Mannheim, Germany) using 250 ng of the re-
spective PCR product as template.
Paraffin sections were prepared for ISH by dewaxing and
rehydration in 0.1 M PBS buffer, followed by proteinase
K-incubation (10 µg/ml) for 20 min at 37°C. For ISH, the
Boehringer protocol for non-radioactive ISH using digox-
igenin-labeled RNA probes was used. Briefly, sections
were pretreated with PBS containing 0.1% Triton X-100.
Hybridization was performed with 50% deionized forma-
mide, 10% dextran sulfate, 5 × Denhardt's solution, 0.5 M
Tris (pH 7.0),10% laurylsarcosine, 1% ssDNA, 0.1% tRNA
(10 mg/ml), 0.1% 0.5 M EDTA (pH 8,0). Sections were in-
cubated with 100 µl hybridization mixture containing
200 ng of digoxigenin labeled antisense or sense RNA
probe at 55°C overnight. The slides were then washed ex-
tensively, treated with 2 × SSC containing 20 µl/ml RNAse
at 37°. To reduce background staining, slides were
washed in 2 × SSC with and without 50% formamide at
50°C in a shaking water bath.
To detect digoxigenin labeled RNA probes, slides were in-
cubated with sheep anti-DIG-alkaline phosphatase anti-
body (#1093274, Boehringer Mannheim, Germany) at a
dilution of 1:1000 in a humid chamber at 4°C overnight.
After washing in a buffer containing 100 mM Tris-HCl
(pH 9,5), 100 mM NaCl and 50 mM MgCl2, the sections
were incubated with the same buffer containing 0.45% ni-
troblue tetrazolium and 0.35% X-phosphate (5-bromo-4-
chloro-3-indolylphosphate) at room temperature. The re-
action was stopped after the colored signal appeared (withBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/8
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no or only weak background in the sections incubated
with the sense RNA probe). Sections were coverslipped
with ICN aqueous mounting solution.
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